Therapeutic Research in Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

6,388

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Multiple Myeloma
Interventions
OTHER

No drugs are involved

No treatment or drugs are involved in this research. Participating in this study requires that blood and bone marrow samples be obtained as a part of the diagnostic work-up or follow-up of participant's multiple myeloma. Bone marrow/peripheral blood samples will be collected at the same time for research purposes. Data will be collected including demographic information gathered from your medical record, including gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology results, treatment protocols, dates of relapses, subsequent treatment protocols, and current treatments and medications.

Trial Locations (1)

72205

University of Arkansas for Medical Sciences/MIRT, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT00572338 - Therapeutic Research in Multiple Myeloma | Biotech Hunter | Biotech Hunter